Pacific Biosciences Of California (PACB) EBT Margin (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly EBT Margin of 21.76% for Q1 2026, up 112586.0% year-over-year from N/an in Q1 2025, and up 75.81% quarter-over-quarter from 89.97% in Q4 2025.
Pacific Biosciences Of California (PACB) EBT Margin (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's EBT Margin history runs 17 years deep, the most recent figure standing at 21.76% for Q1 2026.
- In Q1 2026, EBT Margin rose 112586.0% year-over-year to 21.76%; the TTM figure through Mar 2026 stood at 79.84% (up 35186.0% YoY), while the FY2025 annual figure was 341.28%, down 14030.0% from the prior year.
- EBT Margin for Q1 2026 stood at 21.76%, up from 89.97% in the prior quarter.
- The five-year high for EBT Margin was 6.85% in Q4 2024, with the low at 1147.62% in Q1 2025.
- The 5-year median for EBT Margin is 151.94% (2024), against an average of 231.66%.
- The sharpest annual moves came in 2025 and 2026: EBT Margin slumped 94619 bps in 2025, then surged 112586 bps in 2026.
- Pacific Biosciences Of California's EBT Margin stood at 308.5% in 2022, then jumped by 54 bps to 141.78% in 2023, then jumped by 105 bps to 6.85% in 2024, then plunged by 1413 bps to 89.97% in 2025, then surged by 76 bps to 21.76% in 2026.
- Business Quant data shows PACB's EBT Margin at 21.76% in Q1 2026, 89.97% in Q4 2025, and 97.86% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 18.32% |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | -114.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -114.55% |
| Mar 31, 2026 | -21.76% |
| Dec 31, 2025 | -89.97% |
| Sep 30, 2025 | -97.86% |
| Jun 30, 2025 | -105.35% |
| Mar 31, 2025 | -1,147.62% |
| Dec 31, 2024 | 6.85% |
| Sep 30, 2024 | -151.94% |
| Jun 30, 2024 | -481.27% |
| Mar 31, 2024 | -201.44% |
| Dec 31, 2023 | -141.78% |
| Sep 30, 2023 | -139.30% |
| Jun 30, 2023 | -146.79% |
| Mar 31, 2023 | -226.26% |
| Dec 31, 2022 | -308.50% |
| Sep 30, 2022 | -238.22% |
| Jun 30, 2022 | -201.30% |
| Mar 31, 2022 | -245.68% |
| Dec 31, 2021 | -189.22% |
| Jun 30, 2021 | -288.10% |